Can lead to signs of irritation such as burning sensation, itching or skin rash at the site of application; hypersensitivity reactions.
Flumethasone is a moderately potent difluorinated corticosteroid ester with anti-inflammatory, antipruritic and vasoconstrictive properties. As it is a privalate salt, its anti-inflammatory action is concentrated at the site of application. This local effect on diseased areas results in a prompt decrease in inflammation, exudation and itching.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Denosumab | The risk or severity of adverse effects can be increased when Denosumab is combined with Flumethasone. |
| Natalizumab | The risk or severity of immunosuppression can be increased when Flumethasone is combined with Natalizumab. |
| Pimecrolimus | The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Flumethasone. |
| Roflumilast | Roflumilast may increase the immunosuppressive activities of Flumethasone. |
| Sipuleucel-T | The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Flumethasone. |
| Ceritinib | The risk or severity of hyperglycemia can be increased when Flumethasone is combined with Ceritinib. |
| Corticorelin ovine triflutate | The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Flumethasone. |
| Deferasirox | The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Flumethasone is combined with Deferasirox. |
| Amphotericin B | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Amphotericin B. |
| Isoetharine | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Isoetharine. |
| Norepinephrine | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Norepinephrine. |
| Phenylpropanolamine | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Phenylpropanolamine. |
| Epinephrine | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Epinephrine. |
| Orciprenaline | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Orciprenaline. |
| Dobutamine | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Dobutamine. |
| Ritodrine | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Ritodrine. |
| Bitolterol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Bitolterol. |
| Salmeterol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Salmeterol. |
| Formoterol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Formoterol. |
| Albuterol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Salbutamol. |
| Isoprenaline | The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Flumethasone. |
| Arbutamine | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Arbutamine. |
| Arformoterol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Arformoterol. |
| Fenoterol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Fenoterol. |
| Pirbuterol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Pirbuterol. |
| Ephedra sinica root | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Ephedra sinica root. |
| Procaterol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Procaterol. |
| Clenbuterol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Clenbuterol. |
| Celiprolol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Celiprolol. |
| Indacaterol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Indacaterol. |
| Droxidopa | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Droxidopa. |
| Protokylol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Protokylol. |
| Hexoprenaline | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Hexoprenaline. |
| Olodaterol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Olodaterol. |
| Vilanterol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Vilanterol. |
| Doxofylline | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Doxofylline. |
| Racepinephrine | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Racepinephrine. |
| Etafedrine | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Etafedrine. |
| PF-00610355 | The risk or severity of hypokalemia can be increased when Flumethasone is combined with PF-00610355. |
| Abediterol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Abediterol. |
| Batefenterol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Batefenterol. |
| Levosalbutamol | The risk or severity of hypokalemia can be increased when Flumethasone is combined with Levosalbutamol. |
| Mitotane | The serum concentration of Flumethasone can be decreased when it is combined with Mitotane. |
| Dicoumarol | Flumethasone may increase the anticoagulant activities of Dicoumarol. |
| Phenindione | Flumethasone may increase the anticoagulant activities of Phenindione. |
| Warfarin | Flumethasone may increase the anticoagulant activities of Warfarin. |
| Phenprocoumon | Flumethasone may increase the anticoagulant activities of Phenprocoumon. |
| Acenocoumarol | Flumethasone may increase the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | Flumethasone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Coumarin | Flumethasone may increase the anticoagulant activities of Coumarin. |
| (R)-warfarin | Flumethasone may increase the anticoagulant activities of (R)-warfarin. |
| Ethyl biscoumacetate | Flumethasone may increase the anticoagulant activities of Ethyl biscoumacetate. |
| Fluindione | Flumethasone may increase the anticoagulant activities of Fluindione. |
| Clorindione | Flumethasone may increase the anticoagulant activities of Clorindione. |
| Diphenadione | Flumethasone may increase the anticoagulant activities of Diphenadione. |
| Tioclomarol | Flumethasone may increase the anticoagulant activities of Tioclomarol. |
| (S)-Warfarin | Flumethasone may increase the anticoagulant activities of (S)-Warfarin. |
| Sulfamethoxazole | The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Flumethasone. |
| Leflunomide | The risk or severity of adverse effects can be increased when Flumethasone is combined with Leflunomide. |
| Tofacitinib | Flumethasone may increase the immunosuppressive activities of Tofacitinib. |
| Trastuzumab | The risk or severity of neutropenia can be increased when Trastuzumab is combined with Flumethasone. |
| Fingolimod | Flumethasone may increase the immunosuppressive activities of Fingolimod. |
| Nicorandil | The risk or severity of ulceration can be increased when Flumethasone is combined with Nicorandil. |
| Tacrolimus | Tacrolimus may increase the immunosuppressive activities of Flumethasone. |
| Calcitriol | The therapeutic efficacy of Calcitriol can be decreased when used in combination with Flumethasone. |
| Calcifediol | The therapeutic efficacy of Calcifediol can be decreased when used in combination with Flumethasone. |
| Ergocalciferol | The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Flumethasone. |
| Cholecalciferol | The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Flumethasone. |
| Paricalcitol | The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Flumethasone. |
| Dihydrotachysterol | The therapeutic efficacy of Dihydrotachysterol can be decreased when used in combination with Flumethasone. |
| Alfacalcidol | The therapeutic efficacy of Alfacalcidol can be decreased when used in combination with Flumethasone. |
| Seocalcitol | The therapeutic efficacy of Seocalcitol can be decreased when used in combination with Flumethasone. |
| Inecalcitol | The therapeutic efficacy of Inecalcitol can be decreased when used in combination with Flumethasone. |
| Becocalcidiol | The therapeutic efficacy of Becocalcidiol can be decreased when used in combination with Flumethasone. |
| Eldecalcitol | The therapeutic efficacy of Eldecalcitol can be decreased when used in combination with Flumethasone. |
| 1alpha,24S-Dihydroxyvitamin D2 | The therapeutic efficacy of 1alpha,24S-Dihydroxyvitamin D2 can be decreased when used in combination with Flumethasone. |
| Elocalcitol | The therapeutic efficacy of Elocalcitol can be decreased when used in combination with Flumethasone. |
| Maxacalcitol | The therapeutic efficacy of Maxacalcitol can be decreased when used in combination with Flumethasone. |
| Doxercalciferol | The therapeutic efficacy of Doxercalciferol can be decreased when used in combination with Flumethasone. |
| Vitamin D | The therapeutic efficacy of Vitamin D can be decreased when used in combination with Flumethasone. |
| 1alpha-Hydroxyvitamin D5 | The therapeutic efficacy of 1alpha-Hydroxyvitamin D5 can be decreased when used in combination with Flumethasone. |
| Previtamin D(3) | The therapeutic efficacy of Previtamin D(3) can be decreased when used in combination with Flumethasone. |
| Mifepristone | The serum concentration of Flumethasone can be increased when it is combined with Mifepristone. |
| Diethylstilbestrol | The serum concentration of Flumethasone can be increased when it is combined with Diethylstilbestrol. |
| Etonogestrel | The serum concentration of Flumethasone can be increased when it is combined with Etonogestrel. |
| Desogestrel | The serum concentration of Flumethasone can be increased when it is combined with Desogestrel. |
| Megestrol acetate | The serum concentration of Flumethasone can be increased when it is combined with Megestrol acetate. |
| Levonorgestrel | The serum concentration of Flumethasone can be increased when it is combined with Levonorgestrel. |
| Progesterone | The serum concentration of Flumethasone can be increased when it is combined with Progesterone. |
| Medroxyprogesterone acetate | The serum concentration of Flumethasone can be increased when it is combined with Medroxyprogesterone acetate. |
| Norethisterone | The serum concentration of Flumethasone can be increased when it is combined with Norethisterone. |
| Estradiol | The serum concentration of Flumethasone can be increased when it is combined with Estradiol. |
| Ethynodiol diacetate | The serum concentration of Flumethasone can be increased when it is combined with Ethynodiol diacetate. |
| Norgestimate | The serum concentration of Flumethasone can be increased when it is combined with Norgestimate. |
| Ethinylestradiol | The serum concentration of Flumethasone can be increased when it is combined with Ethinylestradiol. |
| Mestranol | The serum concentration of Flumethasone can be increased when it is combined with Mestranol. |
| Drospirenone | The serum concentration of Flumethasone can be increased when it is combined with Drospirenone. |
| Estrone sulfate | The serum concentration of Flumethasone can be increased when it is combined with Estrone sulfate. |
| Octylphenoxy polyethoxyethanol | The serum concentration of Flumethasone can be increased when it is combined with Octylphenoxy polyethoxyethanol. |
| Cyproterone acetate | The serum concentration of Flumethasone can be increased when it is combined with Cyproterone acetate. |